Should COVID-19 be considered cardiovascular disease risk equivalent?
作者信息
Kow Chia Siang, Ramachandram Dinesh Sangarran, Hasan Syed Shahzad
机构信息
School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
出版信息
Int J Cardiol. 2023 Apr 15;377:123. doi: 10.1016/j.ijcard.2023.01.076. Epub 2023 Jan 29.
Abstract
摘要
相似文献
1
Should COVID-19 be considered cardiovascular disease risk equivalent?新型冠状病毒肺炎应被视为心血管疾病风险等同情况吗？
Int J Cardiol. 2023 Apr 15;377:123. doi: 10.1016/j.ijcard.2023.01.076. Epub 2023 Jan 29.
2
COVID-19 with Cardiovascular Disease: Can It Help Predict Prognosis?患有心血管疾病的COVID-19：它能帮助预测预后吗？
Heart Surg Forum. 2020 Nov 30;23(6):E895-E896. doi: 10.1532/hsf.3301.
3
Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors.急性心肌损伤作为无心血管危险因素患者中COVID-19的唯一表现。
Cardiol J. 2022;29(5):878-879. doi: 10.5603/CJ.2022.0083.
4
Editorial commentary: COVID-19 as a cardiovascular disease risk factor.编辑评论：新冠病毒病作为一种心血管疾病风险因素
Trends Cardiovasc Med. 2022 Nov;32(8):476-478. doi: 10.1016/j.tcm.2022.07.003. Epub 2022 Jul 16.
5
Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease.心跳：患有心血管疾病的年轻患者感染新冠病毒的风险更高。
Heart. 2021 Mar;107(5):345-347. doi: 10.1136/heartjnl-2021-319052.
6
[Effect of cardiovascular risk on SARS-CoV-2 RNA clearance in nasopharyngeal swabs from COVID-19 patients].[心血管风险对新型冠状病毒肺炎患者鼻咽拭子中严重急性呼吸综合征冠状病毒2 RNA清除的影响]
Rev Esp Salud Publica. 2024 Mar 1;98:e1-e4.
7
An Overview on COVID-19 and its Effect on Cardiovascular Diseases.关于 COVID-19 及其对心血管疾病影响的概述。
Endocr Metab Immune Disord Drug Targets. 2021;21(11):1949-1953. doi: 10.2174/1871530321999201228214718.
8
Taking a 'stand' against cardiovascular disease in the era of COVID-19.在新冠疫情时代抗击心血管疾病
Vasc Med. 2021 Aug;26(4):383-385. doi: 10.1177/1358863X211012750. Epub 2021 May 14.
9
Association between cardiovascular manifestation and COVID-19.心血管表现与新型冠状病毒肺炎之间的关联
Clin Cardiol. 2020 Oct;43(10):1053. doi: 10.1002/clc.23423. Epub 2020 Jul 15.
10
Correspondence on 'Coronavirus disease 2019 in patients with cardiovascular disease'.关于“心血管疾病患者的2019冠状病毒病”的通信
J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):e42. doi: 10.2459/JCM.0000000000001276.
引用本文的文献
1
The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence.新冠病毒疫苗接种对心血管系统的潜在益处：来自流感疫苗的经验教训及新出现的证据
Cardiovasc Drugs Ther. 2024 Jun;38(3):421-422. doi: 10.1007/s10557-023-07485-6. Epub 2023 Jul 8.
2
Reply to "Letter to the editor in response to the paper by Zuin et al. 2023".对《致编辑的信：回应祖因等人2023年的论文》的回复
Int J Cardiol. 2023 Apr 1;376:26. doi: 10.1016/j.ijcard.2023.02.014. Epub 2023 Feb 12.
本文引用的文献
1
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis.白细胞介素-6 水平升高与长新冠有关：系统评价和荟萃分析。
Infect Dis Poverty. 2023 Apr 24;12(1):43. doi: 10.1186/s40249-023-01086-z.
2
Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis.新冠康复后急性心肌梗死风险增加：系统评价和荟萃分析。
Int J Cardiol. 2023 Feb 1;372:138-143. doi: 10.1016/j.ijcard.2022.12.032. Epub 2022 Dec 16.
3
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae.持续性中性粒细胞相关免疫特征可作为新冠病毒感染后肺部后遗症的标志物。
Sci Transl Med. 2022 Nov 16;14(671):eabo5795. doi: 10.1126/scitranslmed.abo5795.
4
Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights.中性粒细胞胞外陷阱参与心血管疾病：最新的实验和临床研究进展。
Circ Res. 2020 Apr 24;126(9):1228-1241. doi: 10.1161/CIRCRESAHA.120.315931. Epub 2020 Apr 23.
5
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.炎症细胞因子与冠心病风险：一项新的前瞻性研究和更新的荟萃分析。
Eur Heart J. 2014 Mar;35(9):578-89. doi: 10.1093/eurheartj/eht367. Epub 2013 Sep 10.
6
Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures.他汀类药物能有效降低平滑肌细胞/单核细胞共培养物中细胞因子介导的白细胞介素 6 释放。
J Cell Mol Med. 2011 Apr;15(4):994-1004. doi: 10.1111/j.1582-4934.2010.01036.x.
7
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.血管紧张素II和白细胞介素6在人冠状动脉粥样硬化斑块中的表达：对炎症和斑块不稳定性的潜在影响
Circulation. 2000 Mar 28;101(12):1372-8. doi: 10.1161/01.cir.101.12.1372.
Zotero 插件